First batch recall for therapeutic cannabis trials
Just over a week after the launch of medical cannabis trials, This first batch recall follows a number of incidents reported to the French National Agency for the Safety of Medicines (ANSM).
According to our information, the product in question, distributed by French laboratory Medipha, is the oral solution (10% THC / 10% CBD) from Canadian producer Tilray, a full-spectrum oil containing 10 mg/mL THC and 10 mg/mL CBD, which is said to be leaking from the bottle cap.
The recall will take place shortly, and the drug can no longer be prescribed for the time being. To avoid any further delay in the start of the trial, the batch's secondary supplier - Australian cannabis producer Little Green Pharma in partnership with French pharmaceutical company Intsel Chimos - is set to take over.
The same product had already suffered recalls as part of Germany's medical cannabis program, this time due to too low a THC content compared to what was labeled.
When contacted, Tilray did not respond to our request.
South Australia is working to identify more water-efficient hemp varieties
Massachusetts voters will vote in November on whether to repeal the legalization of cannabis
[Le trois-feuilles] The 2026 World Cup Provides a Global Showcase for Legal Cannabis
Wyoming Rejects the Reclassification of Cannabis
Medical Cannabis: The third edition of Science in the City will be held in Paris on September 28 and 29, 2026
Italian courts continue to weaken the ban on CBD flowers in Italy
The Cayman Islands Are Taking a Cautious Approach to the Decriminalization of Cannabis
China Invests $10 Million in Medical Cannabis in Lebanon
Novel Foods, Excise Taxes, DGAL Inspections: Why CBD Flowers Are the Big Survivors of 2026
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in France3 weeks agoFrance Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France4 weeks ago
French Prime Minister Calls for Drug Testing in Government Ministries
-
Cannabis in Ukraine4 weeks ago
Ukraine Issues Its First Medical Cannabis Prescriptions to Veterans
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
You must be logged in to post a comment Login